Skip to main contentSkip to navigation
Sirius Investors

GRUSF Stock: Grown Rogue International Inc. Stock Price, Analysis & Insights

Get live GRUSF stock price $0.45, comprehensive Grown Rogue International Inc. stock analysis, charts, news, and expert forecast. Real-time GRUSF stock data and investment insights.

0.45
3.17%Today
GRUSFGrown Rogue International Inc. • Other OTC • Healthcare
Market Cap
112.20M
Volume
6.00K
52W High
0.52
52W Low
0.27

Loading chart data...

Grown Rogue International Inc. (GRUSF) Overview

Grown Rogue International Inc. (GRUSF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, GRUSF trades at $0.45 with a market capitalization of 112.20M . Over the past 52 weeks, GRUSF has traded between $0.27 and $0.52 , with the current price positioned at approximately 72% of thi...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 112.20M
  • Current price: $0.45
  • 52-week range: $0.27 - $0.52
  • P/E ratio: 44.89

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Grown Rogue International Inc., operating through its subsidiary entities, focuses on the cultivation and retail of cannabis products across the United States. Its diverse product portfolio includes a variety of cannabis flower, such as indica, sativ...

Company Information

CEO
J. Obie Strickler
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
204

Contact Information

Address
550 Airport Road
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 44.9)

Lower volatility stock (Beta: -1.03) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Grown Rogue International Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Grown Rogue International Inc.
  • Investors should consider how Grown Rogue International Inc. fits within their overall portfolio allocation
  • Premium valuation (P/E: 44.9) requires strong growth to justify

Market Cap

112.20M

P/E Ratio (TTM)

44.89

Beta

-1.03

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.